Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

10 Nov 2014 07:00

RNS Number : 5259W
Kingspan Group PLC
10 November 2014
 

Kingspan Group Plc

Interim Management Statement

 

10 November 2014

 

Kingspan Group plc, the global leader in high performance insulation and building envelopes, today issues the following Interim Management Statement, with trading information for the period from 1 July to 30 September 2014.

 

Sales in the nine month period to 30 September were €1.39bn, up 5% on the prior year (+5% constant currency). A solid sales performance was also recorded in the third quarter with revenue up 7% (+5% constant currency) compared to the same period in 2013.

Insulated Panels revenue in the first nine months increased by 9% (+9% constant currency), and by 8% (+7% constant currency) in the third quarter. The UK continued to perform well with encouraging activity across most building segments. After a sluggish second quarter sales performance, Mainland Europe remained weak through the third quarter reflecting somewhat of an abatement in German market activity. The pace of sales growth in North America improved in the third quarter helped by a strong order book as we entered the second half. Order intake also showed a significant improvement over prior year. Activity in Australasia continued the strong trend evident in the first half.

Insulation Board revenue in the first nine months was up 3% (+1% constant currency) compared with the same period last year, and ahead by 6% in quarter three (+2% constant currency). The UK sales performance was positive through the third quarter, and Mainland European sales were relatively stable overall year on year. Further progress in market conversion was evident in Australia during the third quarter.

Environmental revenue in the first nine months was ahead of last year by 1% (-2% constant currency) and by 3% (-3% constant currency) in the third quarter, continuing on the path of relative stabilisation seen earlier in the year.

Access Floors revenue in the first nine months was 4% behind the same period last year (-4% constant currency). Sales in the third quarter were ahead by 11% (+8% constant currency) with continuing momentum evident in UK office construction activity and an improvement in the US relative to a weak first half.

 Net debt at the end of September 2014 was €107.7m, €39.1m lower than at the same point in 2013. The fourth quarter is a seasonally cash generative period and this would indicate net debt levels by year end in the region of €140m after taking account of the acquisitions of Pactiv Insulation (North America) and PAL (UAE). These insulation board businesses were separately acquired in October for a combined consideration of €77m.The relative optimism that prevailed earlier in the year appears to have waned in recent months, particularly in Europe. Whilst our business continues to perform solidly, we nonetheless are mindful of what are currently more tempered 2015 economic forecasts, and remain focused on driving the Kingspan proposition, whatever the macro climate.

The fourth quarter of 2013 was particularly strong for the Group. Notwithstanding that, and with this seasonally important and often variable period to come, we expect to deliver a full-year trading profit in the region of €144m (+17% versus 2013).

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBGUGBGSR
Date   Source Headline
4th May 20074:34 pmRNSDirector/PDMR Shareholding
30th Apr 20074:53 pmRNSVoting Rights and Capital
27th Mar 20072:01 pmRNSAnnual Update Amended
23rd Mar 200712:38 pmRNSAnnual Information Update
15th Mar 20074:11 pmRNSDirector/PDMR Shareholding
5th Mar 20077:02 amRNSFinal Results
11th Jan 200712:31 pmRNSVoting Rights and Capital
22nd Dec 200611:04 amRNSVoting Rights and Capital
22nd Dec 200611:01 amRNSDirector/PDMR Shareholding
18th Dec 20067:01 amRNSTrading Statement
28th Nov 20063:00 pmRNSTrading Update Notification
6th Nov 20063:43 pmRNSAcquisition Update
26th Oct 200611:19 amRNSAcquisition Update
19th Sep 20064:56 pmRNSDirector/PDMR Shareholding
6th Sep 200610:00 amRNSDirector/PDMR Shareholding
5th Sep 20067:02 amRNSInterim Results
4th Jul 20062:00 pmRNSAmended Blocklisting Return
4th Jul 20062:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20069:00 amRNSBlocklisting Interim Review
26th Jun 200610:05 amRNSAcquisition
19th Jun 200610:20 amRNSDirector/PDMR Shareholding
14th Jun 20063:10 pmRNSDirector/PDMR Shareholding
9th Jun 20067:00 amRNSAnalyst Site Visit
1st Jun 20062:07 pmRNSDirector/PDMR Shareholding
26th May 20062:31 pmRNSDirector/PDMR Shareholding
25th May 200612:53 pmRNSAGM Results
25th May 20067:00 amRNSAGM Statement
23rd May 20065:02 pmRNSChairmanStatementNotification
9th May 20067:01 amRNSStatement re Press Comment
3rd May 200610:52 amRNSDirector/PDMR Shareholding
11th Apr 20064:38 pmRNSDirector/PDMR Shareholding
31st Mar 20064:52 pmRNSAnnual Information Update
30th Mar 20065:04 pmRNSHolding(s) in Company
16th Mar 20065:28 pmRNSDirector/PDMR Shareholding
6th Mar 20067:01 amRNSFinal Results
15th Feb 200611:32 amRNSHolding(s) in Company
10th Feb 20065:12 pmRNSHolding(s) in Company
31st Jan 200611:13 amRNSBlocklisting Review
3rd Jan 20067:01 amRNSDirectorate Change
21st Dec 20059:51 amRNSUp-date Analyst's Call
7th Dec 20059:45 amRNSTrading Statement Notificatio
29th Nov 20054:37 pmRNSBlock Listing Application
28th Nov 200510:49 amRNSSIXTYK Housing Award
18th Nov 20055:21 pmRNSDirector/PDMR Shareholding
28th Oct 20053:46 pmRNSDirector/PDMR Shareholding
27th Oct 20055:04 pmRNSHolding(s) in Company
21st Oct 20057:01 amRNSAward Win
11th Oct 20054:17 pmRNSDirector/PDMR Shareholding
4th Oct 20052:46 pmRNSDirector/PDMR Shareholding
28th Sep 20053:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.